| 0 |
DRUG METABOLITE LEVEL |
1 |
0.5000 |
| 1 |
CHEMOTHERAPEUTIC DRUG LEVEL BELOW THERAPEUTIC |
2 |
0.1333 |
| 2 |
PICORNAVIRUS INFECTION |
5 |
0.1163 |
| 3 |
PANCREATIC PSEUDOCYST HAEMORRHAGE |
1 |
0.1000 |
| 4 |
STRUCTURAL BRAIN DISORDER |
1 |
0.1000 |
| 5 |
SEPTIC COAGULOPATHY |
1 |
0.0714 |
| 6 |
PANCREATIC PSEUDOANEURYSM |
1 |
0.0526 |
| 7 |
HEPATOSPLENIC ABSCESS |
1 |
0.0476 |
| 8 |
ENZYME ACTIVITY DECREASED |
1 |
0.0455 |
| 9 |
ENZYME ACTIVITY INCREASED |
1 |
0.0312 |
| 10 |
CONGENITAL APLASIA |
8 |
0.0257 |
| 11 |
PSEUDOHYPONATRAEMIA |
3 |
0.0219 |
| 12 |
ENZYME INHIBITION |
2 |
0.0208 |
| 13 |
BACTEROIDES BACTERAEMIA |
1 |
0.0167 |
| 14 |
CSF WHITE BLOOD CELL COUNT POSITIVE |
1 |
0.0135 |
| 15 |
FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM |
1 |
0.0132 |
| 16 |
PANCREATITIS HAEMORRHAGIC |
5 |
0.0108 |
| 17 |
SEPTIC PULMONARY EMBOLISM |
2 |
0.0103 |
| 18 |
VITH NERVE DISORDER |
1 |
0.0099 |
| 19 |
HYPERTRIGLYCERIDAEMIA |
56 |
0.0096 |
| 20 |
BACILLUS BACTERAEMIA |
1 |
0.0092 |
| 21 |
HERPES SIMPLEX VIRAEMIA |
1 |
0.0080 |
| 22 |
MEDICAL DEVICE SITE ERYTHEMA |
1 |
0.0078 |
| 23 |
ENZYME LEVEL DECREASED |
1 |
0.0076 |
| 24 |
ANTITHROMBIN III DECREASED |
2 |
0.0073 |
| 25 |
PERINEAL ULCERATION |
1 |
0.0071 |
| 26 |
PINEAL GLAND CYST |
1 |
0.0071 |
| 27 |
HYPERINSULINAEMIA |
2 |
0.0065 |
| 28 |
PANCREATITIS NECROTISING |
15 |
0.0065 |
| 29 |
BLOOD INSULIN DECREASED |
1 |
0.0065 |
| 30 |
PANCREATIC PSEUDOCYST |
5 |
0.0064 |
| 31 |
PSEUDOCYST |
2 |
0.0062 |
| 32 |
TREATMENT DELAYED |
10 |
0.0058 |
| 33 |
ABSCESS FUNGAL |
1 |
0.0057 |
| 34 |
INTRACARDIAC MASS |
1 |
0.0056 |
| 35 |
ANISOCORIA |
2 |
0.0053 |
| 36 |
HAEMOFILTRATION |
1 |
0.0053 |
| 37 |
STENT MALFUNCTION |
1 |
0.0051 |
| 38 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
4 |
0.0050 |
| 39 |
NEUTRALISING ANTIBODIES POSITIVE |
2 |
0.0048 |
| 40 |
OCULAR TOXICITY |
5 |
0.0045 |
| 41 |
DISSEMINATED ASPERGILLOSIS |
2 |
0.0042 |
| 42 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 43 |
BINOCULAR EYE MOVEMENT DISORDER |
1 |
0.0035 |
| 44 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
2 |
0.0033 |
| 45 |
VENOOCCLUSIVE LIVER DISEASE |
16 |
0.0032 |
| 46 |
ABDOMINAL COMPARTMENT SYNDROME |
2 |
0.0031 |
| 47 |
CANDIDA PNEUMONIA |
1 |
0.0031 |
| 48 |
KLEBSIELLA TEST POSITIVE |
2 |
0.0031 |
| 49 |
GIARDIASIS |
1 |
0.0029 |
| 50 |
CIRCUMORAL OEDEMA |
1 |
0.0029 |
| 51 |
STRABISMUS |
8 |
0.0027 |
| 52 |
BILE DUCT STENT INSERTION |
1 |
0.0026 |
| 53 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 54 |
PSEUDOMONAS TEST POSITIVE |
2 |
0.0024 |
| 55 |
SUPERFICIAL VEIN THROMBOSIS |
2 |
0.0024 |
| 56 |
CEREBRAL VENOUS SINUS THROMBOSIS |
2 |
0.0024 |
| 57 |
ENTEROVIRUS INFECTION |
2 |
0.0023 |
| 58 |
REFUSAL OF TREATMENT BY RELATIVE |
1 |
0.0022 |
| 59 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
1 |
0.0022 |
| 60 |
BONE INFARCTION |
1 |
0.0022 |
| 61 |
DRUG SPECIFIC ANTIBODY |
3 |
0.0022 |
| 62 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 63 |
HYPOALBUMINAEMIA |
16 |
0.0021 |
| 64 |
MESENTERIC VEIN THROMBOSIS |
2 |
0.0020 |
| 65 |
SPLENIC VEIN THROMBOSIS |
1 |
0.0020 |
| 66 |
CACHEXIA |
10 |
0.0019 |
| 67 |
ATRIAL THROMBOSIS |
4 |
0.0019 |
| 68 |
POSTURING |
1 |
0.0019 |
| 69 |
TRANSVERSE SINUS THROMBOSIS |
1 |
0.0019 |
| 70 |
PULMONARY MUCORMYCOSIS |
1 |
0.0019 |
| 71 |
ASTERIXIS |
2 |
0.0019 |
| 72 |
ANAPHYLACTIC REACTION |
103 |
0.0019 |
| 73 |
DRUG SPECIFIC ANTIBODY PRESENT |
12 |
0.0018 |
| 74 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
1 |
0.0018 |
| 75 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 76 |
PAROTITIS |
2 |
0.0017 |
| 77 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
15 |
0.0017 |
| 78 |
GRUNTING |
1 |
0.0017 |
| 79 |
DRUG LEVEL BELOW THERAPEUTIC |
9 |
0.0016 |
| 80 |
PHARYNGEAL HAEMORRHAGE |
2 |
0.0016 |
| 81 |
SERUM SICKNESS-LIKE REACTION |
1 |
0.0016 |
| 82 |
BACILLUS INFECTION |
1 |
0.0016 |
| 83 |
SOFT TISSUE NECROSIS |
1 |
0.0015 |
| 84 |
HYPERAMMONAEMIA |
7 |
0.0014 |
| 85 |
VASOGENIC CEREBRAL OEDEMA |
1 |
0.0014 |
| 86 |
PANCREATITIS |
71 |
0.0013 |
| 87 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 88 |
FUNGAEMIA |
2 |
0.0013 |
| 89 |
HEPATITIS VIRAL |
1 |
0.0012 |
| 90 |
VASOPLEGIA SYNDROME |
2 |
0.0012 |
| 91 |
ELECTROLYTE IMBALANCE |
14 |
0.0012 |
| 92 |
FUNGAL SEPSIS |
1 |
0.0012 |
| 93 |
SYSTEMIC CANDIDA |
3 |
0.0012 |
| 94 |
PSEUDOMONAL BACTERAEMIA |
1 |
0.0012 |
| 95 |
POLYNEUROPATHY |
14 |
0.0012 |
| 96 |
AXONAL NEUROPATHY |
1 |
0.0011 |
| 97 |
SPLENIC INFARCTION |
2 |
0.0011 |
| 98 |
HYPERSENSITIVITY |
211 |
0.0011 |
| 99 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 100 |
CEREBRAL VENOUS THROMBOSIS |
2 |
0.0011 |
| 101 |
COAGULOPATHY |
18 |
0.0011 |
| 102 |
PSYCHOGENIC SEIZURE |
1 |
0.0011 |
| 103 |
FEBRILE NEUTROPENIA |
71 |
0.0011 |
| 104 |
CEREBRAL THROMBOSIS |
3 |
0.0011 |
| 105 |
ONCOLOGIC COMPLICATION |
1 |
0.0010 |
| 106 |
GASTROINTESTINAL NECROSIS |
3 |
0.0010 |
| 107 |
INFUSION RELATED REACTION |
67 |
0.0010 |
| 108 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 109 |
BLADDER DYSFUNCTION |
1 |
0.0010 |
| 110 |
EAR SWELLING |
2 |
0.0009 |
| 111 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 112 |
HEPATOTOXICITY |
20 |
0.0009 |
| 113 |
EYELID PTOSIS |
9 |
0.0009 |
| 114 |
VITH NERVE PARALYSIS |
1 |
0.0009 |
| 115 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 116 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 117 |
HYPOVOLAEMIC SHOCK |
4 |
0.0008 |
| 118 |
CIRCULATORY COLLAPSE |
14 |
0.0008 |
| 119 |
BLOOD ELECTROLYTES ABNORMAL |
1 |
0.0008 |
| 120 |
TACHYARRHYTHMIA |
2 |
0.0008 |
| 121 |
VENOOCCLUSIVE DISEASE |
2 |
0.0008 |
| 122 |
AMMONIA INCREASED |
4 |
0.0008 |
| 123 |
HEPATOSPLENOMEGALY |
2 |
0.0008 |
| 124 |
OBSTRUCTION GASTRIC |
1 |
0.0008 |
| 125 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
2 |
0.0008 |
| 126 |
MUCORMYCOSIS |
2 |
0.0008 |
| 127 |
TONIC CLONIC MOVEMENTS |
1 |
0.0008 |
| 128 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 129 |
PANCREATITIS ACUTE |
17 |
0.0008 |
| 130 |
SUBDURAL HAEMORRHAGE |
2 |
0.0007 |
| 131 |
EYE MOVEMENT DISORDER |
5 |
0.0007 |
| 132 |
PULSELESS ELECTRICAL ACTIVITY |
3 |
0.0007 |
| 133 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 134 |
RENAL INFARCT |
1 |
0.0007 |
| 135 |
STRIDOR |
2 |
0.0007 |
| 136 |
SUPERINFECTION |
1 |
0.0007 |
| 137 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 138 |
CLOSTRIDIUM DIFFICILE INFECTION |
14 |
0.0006 |
| 139 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 140 |
HYPERGLYCAEMIA |
23 |
0.0006 |
| 141 |
ASPERGILLUS INFECTION |
4 |
0.0006 |
| 142 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 143 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 144 |
DRUG LEVEL DECREASED |
6 |
0.0006 |
| 145 |
SLEEP TALKING |
1 |
0.0006 |
| 146 |
HYPERBILIRUBINAEMIA |
6 |
0.0006 |
| 147 |
HYPERTRANSAMINASAEMIA |
4 |
0.0006 |
| 148 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 149 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 150 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 151 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 152 |
LIPASE INCREASED |
4 |
0.0005 |
| 153 |
BRONCHOPULMONARY ASPERGILLOSIS |
4 |
0.0005 |
| 154 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 155 |
CORONARY ARTERY THROMBOSIS |
1 |
0.0005 |
| 156 |
NEUTROPENIC COLITIS |
1 |
0.0005 |
| 157 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 158 |
EXOPHTHALMOS |
1 |
0.0005 |
| 159 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 160 |
PANCYTOPENIA |
25 |
0.0004 |
| 161 |
MALNUTRITION |
5 |
0.0004 |
| 162 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 163 |
ACUTE HEPATIC FAILURE |
6 |
0.0004 |
| 164 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 165 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 166 |
DRUG LEVEL INCREASED |
7 |
0.0004 |
| 167 |
BACTERAEMIA |
5 |
0.0004 |
| 168 |
PULSE ABSENT |
2 |
0.0004 |
| 169 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 170 |
PULSE ABNORMAL |
1 |
0.0004 |
| 171 |
INTRAVENTRICULAR HAEMORRHAGE |
1 |
0.0004 |
| 172 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 173 |
NEUROTOXICITY |
7 |
0.0004 |
| 174 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 175 |
SEPTIC SHOCK |
17 |
0.0004 |
| 176 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 177 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
11 |
0.0004 |
| 178 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 179 |
MUCOSAL INFLAMMATION |
10 |
0.0004 |
| 180 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 181 |
PROCTITIS |
1 |
0.0004 |
| 182 |
ENTEROCOLITIS |
2 |
0.0003 |
| 183 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 184 |
EMERGENCY CARE |
1 |
0.0003 |
| 185 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 186 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 187 |
TACHYCARDIA |
28 |
0.0003 |
| 188 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 189 |
LIVER ABSCESS |
1 |
0.0003 |
| 190 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 191 |
HYPOVENTILATION |
1 |
0.0003 |
| 192 |
THERAPY CHANGE |
3 |
0.0003 |
| 193 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 194 |
RESPIRATORY DISTRESS |
8 |
0.0003 |
| 195 |
DROOLING |
2 |
0.0003 |
| 196 |
EAR PRURITUS |
1 |
0.0003 |
| 197 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 198 |
EMBOLIC STROKE |
1 |
0.0003 |
| 199 |
RETCHING |
6 |
0.0003 |
| 200 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 201 |
AMYLASE INCREASED |
1 |
0.0003 |
| 202 |
HEPATIC STEATOSIS |
5 |
0.0003 |
| 203 |
THERAPY NON-RESPONDER |
12 |
0.0003 |
| 204 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
0.0003 |
| 205 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 206 |
POLYDIPSIA |
1 |
0.0003 |
| 207 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 208 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 209 |
COLITIS |
9 |
0.0002 |
| 210 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 211 |
HYPOPHAGIA |
6 |
0.0002 |
| 212 |
MYOPATHY |
2 |
0.0002 |
| 213 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 214 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 215 |
PAPILLOEDEMA |
1 |
0.0002 |
| 216 |
RESPIRATORY FAILURE |
16 |
0.0002 |
| 217 |
GASTROINTESTINAL HAEMORRHAGE |
18 |
0.0002 |
| 218 |
HEPATIC ENCEPHALOPATHY |
2 |
0.0002 |
| 219 |
ATELECTASIS |
2 |
0.0002 |
| 220 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 221 |
HEPATOMEGALY |
2 |
0.0002 |
| 222 |
ANGIOEDEMA |
9 |
0.0002 |
| 223 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 224 |
HYPOTONIA |
2 |
0.0002 |
| 225 |
DRUG TOLERANCE |
1 |
0.0002 |
| 226 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 227 |
CEREBRAL HAEMORRHAGE |
7 |
0.0002 |
| 228 |
ENDOCARDITIS |
1 |
0.0002 |
| 229 |
UNRESPONSIVE TO STIMULI |
5 |
0.0002 |
| 230 |
NEUTROPENIA |
26 |
0.0002 |
| 231 |
CYANOSIS |
3 |
0.0002 |
| 232 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 233 |
POLYARTHRITIS |
1 |
0.0002 |
| 234 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 235 |
SEPSIS |
21 |
0.0002 |
| 236 |
HYPOGLYCAEMIA |
9 |
0.0002 |
| 237 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 238 |
HYDROCEPHALUS |
1 |
0.0002 |
| 239 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 240 |
LIP SWELLING |
6 |
0.0002 |
| 241 |
FUNGAL INFECTION |
6 |
0.0002 |
| 242 |
NECROSIS |
1 |
0.0002 |
| 243 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 244 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 245 |
CANDIDA INFECTION |
3 |
0.0002 |
| 246 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 247 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 248 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 249 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 250 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 251 |
GANGRENE |
1 |
0.0002 |
| 252 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 253 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 254 |
OLIGURIA |
1 |
0.0002 |
| 255 |
ENTERITIS |
1 |
0.0002 |
| 256 |
HERPES SIMPLEX |
1 |
0.0002 |
| 257 |
SKIN MASS |
1 |
0.0001 |
| 258 |
MENINGITIS |
1 |
0.0001 |
| 259 |
CYTOKINE RELEASE SYNDROME |
3 |
0.0001 |
| 260 |
TACHYPNOEA |
2 |
0.0001 |
| 261 |
CARDIAC ARREST |
12 |
0.0001 |
| 262 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 263 |
ENCEPHALITIS |
1 |
0.0001 |
| 264 |
THROMBOCYTOPENIA |
16 |
0.0001 |
| 265 |
HYPOXIA |
5 |
0.0001 |
| 266 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 267 |
FLUSHING |
14 |
0.0001 |
| 268 |
ASCITES |
4 |
0.0001 |
| 269 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 270 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 271 |
HEPATIC FAILURE |
4 |
0.0001 |
| 272 |
ACIDOSIS |
1 |
0.0001 |
| 273 |
SHOCK |
3 |
0.0001 |
| 274 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 275 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 276 |
RENAL FAILURE |
17 |
0.0001 |
| 277 |
HAEMORRHAGE |
13 |
0.0001 |
| 278 |
HYPONATRAEMIA |
7 |
0.0001 |
| 279 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 280 |
HAEMODIALYSIS |
1 |
0.0001 |
| 281 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 282 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 283 |
GROIN PAIN |
1 |
0.0001 |
| 284 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 285 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 286 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 287 |
ACUTE KIDNEY INJURY |
17 |
0.0001 |
| 288 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 289 |
URTICARIA |
18 |
0.0001 |
| 290 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 291 |
NEPHROPATHY |
1 |
0.0001 |
| 292 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 293 |
FLANK PAIN |
1 |
0.0001 |
| 294 |
LEUKAEMIA |
1 |
0.0001 |
| 295 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 296 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 297 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 298 |
CHOKING |
2 |
0.0001 |
| 299 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 300 |
EAR DISCOMFORT |
1 |
0.0001 |
| 301 |
PERITONITIS |
2 |
0.0001 |
| 302 |
PETECHIAE |
1 |
0.0001 |
| 303 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 304 |
SUDDEN DEATH |
1 |
0.0001 |
| 305 |
PRODUCT USE ISSUE |
17 |
0.0001 |
| 306 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 307 |
INFECTION |
13 |
0.0001 |
| 308 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 309 |
THROMBOSIS |
7 |
0.0001 |
| 310 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 311 |
SPLENOMEGALY |
1 |
0.0001 |
| 312 |
COUGH |
23 |
0.0001 |
| 313 |
ILEUS |
1 |
0.0001 |
| 314 |
VOMITING |
36 |
0.0001 |
| 315 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 316 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 317 |
JAUNDICE |
2 |
0.0001 |
| 318 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 319 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 320 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 321 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 322 |
DIALYSIS |
1 |
0.0001 |
| 323 |
BRONCHOSPASM |
1 |
0.0001 |
| 324 |
SEIZURE |
8 |
0.0001 |
| 325 |
GASTROENTERITIS |
1 |
0.0001 |
| 326 |
WHEEZING |
4 |
0.0001 |
| 327 |
THROAT IRRITATION |
3 |
0.0001 |
| 328 |
PLEURAL EFFUSION |
4 |
0.0001 |
| 329 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 330 |
HYPOTENSION |
13 |
0.0001 |
| 331 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 332 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 333 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 334 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 335 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 336 |
HEART RATE INCREASED |
6 |
0.0001 |
| 337 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 338 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 339 |
VIRAL INFECTION |
2 |
0.0001 |
| 340 |
THERAPY CESSATION |
3 |
0.0001 |
| 341 |
ANAEMIA |
11 |
0.0001 |
| 342 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 343 |
HYPERKALAEMIA |
2 |
0.0001 |
| 344 |
COLD SWEAT |
1 |
0.0001 |
| 345 |
OSTEOMYELITIS |
1 |
0.0001 |
| 346 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 347 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 348 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 349 |
ABDOMINAL PAIN |
12 |
0.0001 |
| 350 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 351 |
STOMATITIS |
3 |
0.0000 |
| 352 |
FEEDING DISORDER |
1 |
0.0000 |
| 353 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 354 |
HYPERHIDROSIS |
6 |
0.0000 |
| 355 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 356 |
SWELLING FACE |
3 |
0.0000 |
| 357 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 358 |
LIVER DISORDER |
2 |
0.0000 |
| 359 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 360 |
DRUG INTERACTION |
7 |
0.0000 |
| 361 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 362 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 363 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 364 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 365 |
AGITATION |
3 |
0.0000 |
| 366 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 367 |
PRODUCT USE IN UNAPPROVED INDICATION |
10 |
0.0000 |
| 368 |
SYNCOPE |
4 |
0.0000 |
| 369 |
HEPATITIS |
1 |
0.0000 |
| 370 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 371 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 372 |
PYREXIA |
13 |
0.0000 |
| 373 |
PALLOR |
1 |
0.0000 |
| 374 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 375 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 376 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 377 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 378 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 379 |
CYSTITIS |
1 |
0.0000 |
| 380 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 381 |
GAIT INABILITY |
1 |
0.0000 |
| 382 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 383 |
ERYTHEMA |
6 |
0.0000 |
| 384 |
NAUSEA |
23 |
0.0000 |
| 385 |
RASH MACULAR |
1 |
0.0000 |
| 386 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 387 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 388 |
CRYING |
1 |
0.0000 |
| 389 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 390 |
EPISTAXIS |
2 |
0.0000 |
| 391 |
DYSARTHRIA |
1 |
0.0000 |
| 392 |
BLINDNESS |
1 |
0.0000 |
| 393 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 394 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 395 |
POLLAKIURIA |
1 |
0.0000 |
| 396 |
DEHYDRATION |
3 |
0.0000 |
| 397 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 398 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 399 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 400 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 401 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 402 |
LEUKOPENIA |
1 |
0.0000 |
| 403 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 404 |
DYSPNOEA |
11 |
0.0000 |
| 405 |
HYPERTENSION |
4 |
0.0000 |
| 406 |
BRADYCARDIA |
1 |
0.0000 |
| 407 |
PRURITUS |
7 |
0.0000 |
| 408 |
MEDICATION ERROR |
1 |
0.0000 |
| 409 |
NECK PAIN |
1 |
0.0000 |
| 410 |
CHILLS |
2 |
0.0000 |
| 411 |
IRRITABILITY |
1 |
0.0000 |
| 412 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 413 |
VERTIGO |
1 |
0.0000 |
| 414 |
FEELING HOT |
1 |
0.0000 |
| 415 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 416 |
CONSTIPATION |
3 |
0.0000 |
| 417 |
DYSGEUSIA |
1 |
0.0000 |
| 418 |
BACK PAIN |
3 |
0.0000 |
| 419 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 420 |
FEELING ABNORMAL |
3 |
0.0000 |
| 421 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 422 |
TREMOR |
2 |
0.0000 |
| 423 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 424 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 425 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 426 |
ADVERSE EVENT |
1 |
0.0000 |
| 427 |
SWELLING |
1 |
0.0000 |
| 428 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 429 |
SINUSITIS |
1 |
0.0000 |
| 430 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 431 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 432 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 433 |
PNEUMONIA |
3 |
0.0000 |
| 434 |
RASH |
4 |
0.0000 |
| 435 |
DECREASED APPETITE |
2 |
0.0000 |
| 436 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 437 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 438 |
ANXIETY |
2 |
0.0000 |
| 439 |
OFF LABEL USE |
6 |
0.0000 |
| 440 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 441 |
HOSPITALISATION |
1 |
0.0000 |
| 442 |
HEADACHE |
4 |
0.0000 |
| 443 |
MYALGIA |
1 |
0.0000 |
| 444 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 445 |
COVID-19 |
1 |
0.0000 |
| 446 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 447 |
CHEST PAIN |
1 |
0.0000 |
| 448 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 449 |
SOMNOLENCE |
1 |
0.0000 |
| 450 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 451 |
DIZZINESS |
2 |
0.0000 |
| 452 |
WEIGHT DECREASED |
1 |
0.0000 |
| 453 |
PAIN |
2 |
0.0000 |
| 454 |
DIARRHOEA |
2 |
0.0000 |
| 455 |
FATIGUE |
2 |
0.0000 |
| 456 |
ARTHRALGIA |
1 |
0.0000 |
| 457 |
DEATH |
2 |
0.0000 |
| 458 |
MALAISE |
1 |
0.0000 |